Search Results - "Swords, R T"

Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary by Watts, J M, Wang, X V, Swords, R T, Paietta, E, Douer, D, Lugar, S M, Fernandez, H F, Rowe, J M, Lazarus, H M, Tallman, M S, Litzow, M R

Get full text

MK-0457, an Aurora kinase and BCR–ABL inhibitor, is active in patients with BCR–ABL T315I leukemia by Giles, F J, Swords, R T, Nagler, A, Hochhaus, A, Ottmann, O G, Rizzieri, D A, Talpaz, M, Clark, J, Watson, P, Xiao, A, Zhao, B, Bergstrom, D, Le Coutre, P D, Freedman, S J, Cortes, J E

“…MK-0457, an Aurora kinase and BCR–ABL inhibitor, was studied on a Phase I/II study in 77 patients with refractory hematologic malignancies. The average number…”
Get full text

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes by Swords, R T, Watts, J, Erba, H P, Altman, J K, Maris, M, Anwer, F, Hua, Z, Stein, H, Faessel, H, Sedarati, F, Dezube, B J, Giles, F J, Medeiros, B C, DeAngelo, D J

Get full text

Effect of sunitinib on TRAIL-induced apoptosis in preclinical colon cancer models by Mahalingam, D., Medina, E., Swords, R. T., Kelly, K. R., Carew, J. S., Robbert, C. H., Szegezdi, E., Francis, G. J., de Jong, S., Nawrocki, S. T.

“…Abstract only e14633 Background: Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) is a potent inducer of apoptosis, however not all cancers…”
Get full text

Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritis by Murphy, Philip T, Fay, Michael J, Swords, Ronan T, Quinn, John P, O'Donnell, John R

Get full text